Louisa Bolm
Massachusetts General Hospital
Appearances
DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…Presenter
Speakers
Massachusetts General HospitalMassachusetts General Hospital- DateMay 18, 2024
Presenter
Massachusetts General Hospital PATIENT-REPORTED OUTCOMES AT THREE MONTHS AFTER PANCREATIC SURGERY FOR BENIGN AND MALIGNANT DISEASES
DateMay 19, 2024Background: Pancreatic surgery involves complex operative procedures and may have a long-lasting effect on patients’ health status and quality of life. Large-scale studies on patient-reported outcomes in patients after pancreatic procedures are warranted…Presenter
Speakers
University Medical Center Schleswig HolsteinMassachusetts General Hospital
DateMay 20, 2024SOCIETY: SSATModerators
Tokyo Ika Shika Daigaku Daigakin Ishigaku Sogo KenkyukaMassachusetts General HospitalYale University School of Medicine- DateMay 21, 2024Background: Ampullary adenocarcinoma (AMPAC) are a rare entity of gastrointestinal malignancies arising from the Ampulla of Vater. Together with distal cholangiocarcinoma (DCC) and duodenal adenocarcinoma (DUOAC) AMPAC form the group of periampullary tumors…
Presenter
Massachusetts General HospitalSpeakers
Massachusetts General HospitalUniversity Medical Center Schleswig Holstein 
DateMay 18, 2024RISK FACTORS FOR REGROWTH AFTER NONOPERATIVE MANAGEMENT FOR RECTAL CANCERModerators
Stony Brook University HospitalCleveland ClinicUniversity of Wisconsin-MadisonUniversity of Alabama at Birmingham (UAB)Speakers
Massachusetts General Hospital
DateMay 4, 2025SOCIETY: SSATModerators
University of ArizonaMassachusetts General HospitalKing George's Medical University
DateMay 4, 2025SOCIETY: SSATModerators
Stony Brook University HospitalCity of HopeMassachusetts General Hospital
